Literature DB >> 17717140

Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat.

Neville N C Tam1, Irwin Leav, Shuk-Mei Ho.   

Abstract

Oxidative and nitrosative stress have been implicated in prostate carcinogenesis, but the cause(s) of redox imbalance in the gland remains poorly defined. We and others have reported that administration of testosterone plus 17beta-estradiol to Noble rats for 16 weeks induces dysplasia and stromal inflammation of the lateral prostate (LP) but not the ventral prostate. Here, using laser capture microdissected specimens, we found that the combined hormone regimen increased the expression of mRNA of specific members of NAD(P)H oxidase (NOX-1, NOX-2, and NOX4), nitric-oxide synthase [NOS; inducible NOS and endothelial NOS], and cyclooxygenase (COX-2) in the LP epithelium and/or its adjacent inflammatory stroma. Accompanying these changes was the accumulation of 8-hydroxy-2'-deoxyguanosine, 4-hydroxynonenal protein adducts, and nitrotyrosine, primarily in the LP epithelium, suggesting that NOX, NOS, and COX may mediate hormone-induced oxidative/nitrosative stress in epithelium. We concluded that the oxidative/nitrosative damage resulting from the testosterone-plus-17beta-estradiol treatment is not solely derived from stromal inflammatory lesions but likely also originates from the epithelium per se. In this context, the up-regulation of COX-2 from epithelium represents a potential mechanism by which the hormone-initiated epithelium might induce inflammatory responses. Thus, we link alterations in the hormonal milieu with oxidative/nitrosative/inflammatory damage to the prostate epithelium that promotes carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17717140      PMCID: PMC1988882          DOI: 10.2353/ajpath.2007.070199

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  Clinical review 134: The endocrinology of prostate cancer.

Authors:  M E Taplin; S M Ho
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

2.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

3.  Reactive oxygen generated by Nox1 triggers the angiogenic switch.

Authors:  Jack L Arbiser; John Petros; Robert Klafter; Baskaran Govindajaran; Elizabeth R McLaughlin; Lawrence F Brown; Cynthia Cohen; Marsha Moses; Susan Kilroy; Rebecca S Arnold; J David Lambeth
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

4.  Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.

Authors:  S Zha; W R Gage; J Sauvageot; E A Saria; M J Putzi; C M Ewing; D A Faith; W G Nelson; A M De Marzo; W B Isaacs
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

Review 5.  Prostaglandins and leukotrienes: advances in eicosanoid biology.

Authors:  C D Funk
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

6.  Aberrant expression of hepatocyte growth factor and its receptor, c-Met, during sex hormone-induced prostatic carcinogenesis in the Noble rat.

Authors:  N N Tam; S S Chung; D T Lee; Y C Wong
Journal:  Carcinogenesis       Date:  2000-12       Impact factor: 4.944

7.  Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer.

Authors:  D G Bostwick; E E Alexander; R Singh; A Shan; J Qian; R M Santella; L W Oberley; T Yan; W Zhong; X Jiang; T D Oberley
Journal:  Cancer       Date:  2000-07-01       Impact factor: 6.860

8.  Localization of antioxidant enzymes and oxidative damage products in normal and malignant prostate epithelium.

Authors:  T D Oberley; W Zhong; L I Szweda; L W Oberley
Journal:  Prostate       Date:  2000-07-01       Impact factor: 4.104

Review 9.  Endogenous estrogens as carcinogens through metabolic activation.

Authors:  J D Yager
Journal:  J Natl Cancer Inst Monogr       Date:  2000

10.  Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats.

Authors:  Neville N C Tam; Shibnath Ghatak; Shuk-Mei Ho
Journal:  Prostate       Date:  2003-04-01       Impact factor: 4.104

View more
  24 in total

1.  Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.

Authors:  Nur Ozten; Lori Horton; Salamia Lasano; Maarten C Bosland
Journal:  Cancer Prev Res (Phila)       Date:  2010-02-23

2.  Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer.

Authors:  Daniel A Barocas; Saundra Motley; Michael S Cookson; Sam S Chang; David F Penson; Qi Dai; Ginger Milne; L Jackson Roberts; Jason Morrow; Raoul S Concepcion; Joseph A Smith; Jay H Fowke
Journal:  J Urol       Date:  2011-04-15       Impact factor: 7.450

Review 3.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

4.  Effects of Black Raspberries and Their Constituents on Rat Prostate Carcinogenesis and Human Prostate Cancer Cell Growth In Vitro.

Authors:  Jillian N Eskra; Alaina Dodge; Michael J Schlicht; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2019-08-12       Impact factor: 2.900

5.  L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL rats.

Authors:  Nur Özten; Michael Schlicht; Alan M Diamond; Maarten C Bosland
Journal:  Nutr Cancer       Date:  2014-04-28       Impact factor: 2.900

6.  A small molecule polyamine oxidase inhibitor blocks androgen-induced oxidative stress and delays prostate cancer progression in the transgenic adenocarcinoma of the mouse prostate model.

Authors:  Hirak S Basu; Todd A Thompson; Dawn R Church; Cynthia C Clower; Farideh Mehraein-Ghomi; Corey A Amlong; Christopher T Martin; Patrick M Woster; Mary J Lindstrom; George Wilding
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

7.  Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats.

Authors:  Hung-Ming Lam; Shuk-Mei Ho; Jing Chen; Mario Medvedovic; Neville Ngai Chung Tam
Journal:  Endocrinology       Date:  2015-10-23       Impact factor: 4.736

8.  Comprehensive identification and modified-site mapping of S-nitrosylated targets in prostate epithelial cells.

Authors:  Ying Wai Lam; Yong Yuan; Jared Isaac; C V Suresh Babu; Jarek Meller; Shuk-Mei Ho
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

9.  The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model.

Authors:  Steffen E Eikenberry; John D Nagy; Yang Kuang
Journal:  Biol Direct       Date:  2010-04-20       Impact factor: 4.540

10.  Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats.

Authors:  Neville N C Tam; Carol Ying-Ying Szeto; Maureen A Sartor; Mario Medvedovic; Shuk-Mei Ho
Journal:  Neoplasia       Date:  2008-01       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.